AB Anywhere: Why List on Binance Alpha?
SINGAPORE, June 7, 2025 /PRNewswire/ -- On June 7, 2025, ABÂ DAO announced…
AB Anywhere: $AB Goes Live on Binance, Ushering in a New Era of Cross-Chain Asset Mobility
DUBLIN, June 7, 2025 /PRNewswire/ -- On June 7, 2025 at 14:00…
NYSE Content Advisory: Pre-Market update + Circle shares surge in first day of trading
NEW YORK, June 6, 2025 /PRNewswire/ -- The New York Stock Exchange…
Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F
June 02, 2025 19:30 ET Â | Source: Semilux International Ltd. Taipei, Taiwan,…
NYSE Content Advisory: Pre-Market update + U.S. – China trade tensions escalate
NEW YORK, June 2, 2025 /PRNewswire/ -- The New York Stock Exchange…
![Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]](https://i0.wp.com/ml-eu.globenewswire.com/media/NjEzMmQ4NzAtZTBkMS00ZDhhLTkyYjgtOGM3YzY1ZWM5M2U5LTEwMTQyODItMjAyNS0wNi0wMi1lbg==/tiny/Sandoz-International-GmbH.png?w=420&resize=420,280&ssl=1 "Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]")
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA…
Celularity Receives Nasdaq Notice Regarding Form 10-Q
May 30, 2025 17:30 ET Â | Source: Celularity Inc. FLORHAM PARK, N.J.,…